Equity Methadone 2 mg / 1 ml Oral Solution
PDF Leaflet Revision Date: 31 July 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Substitution treatment in opiate dependence.
Dosage (summary)
Initial: 20 mg once daily, adjust to 60-120 mg based on clinical assessment.
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- CYP3A4 inhibitors
- CYP3A4 inducers
- CNS depressants
Contraindications
- Hypersensitivity
- Respiratory depression
- Acute obstructive airway disease
- Children
Common side effects
- Respiratory depression
- Nausea
- Constipation
- Sedation
Counselling Points
- Avoid alcohol and CNS depressants
- Store safely away from children
- Monitor for signs of overdose
Serious warnings
- QT prolongation
- Risk of overdose
- Addiction potential
Important Disclaimer
The Equity Methadone 2 mg / 1 ml Oral Solution professional information leaflet below is the property of Equity Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
